Thursday, November 21, 2024

Wegovy gets FDA approval to reduce risk of heart issues in overweight adults

Must read




The FDA on Friday said it approved Novo Nordisk’s popular weight-loss drug Wegovy to reduce the risk of severe heart issues in overweight or obese adults.



Source link

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article